Fig. 1
The three key steps followed to conduct early cost-effectiveness analysis. Step#1:Narowing the scope of the economic evaluation, building a conceptual economic model and drafting scenarios for the new prognostic tool (i.e. Straticyte™); Step #2: Inventory of available evidence from internal unpublished resources, systematic review and meta-analysis as well as by utilizing belief elicitation methods to gather scarce evidence where necessary; Step#3: Determining the cost-effectiveness of the Straticyte™ by conducting a base case analysis, scenario analyses and sensitivity analyses (at least deterministic given scarce evidence)